Cofirasersen

Names

[ Name ]:
Cofirasersen

Biological Activity

[Description]:

Cofirasersen is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.

[Related Catalog]:

Signaling Pathways >> Membrane Transporter/Ion Channel >> Sodium Channel

Research Areas >> Others

[References]

[1]. WHO Drug Information, Vol. 34, No. 3, 2020

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₇₂H₂₁₈N₅₇O₈₈P₁₅S₁₅

[ Molecular Weight ]:
5437.55

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.